L R Baden

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)
    Lindsey R Baden
    Brigham and Women s Hospital, Rockville, Maryland, USA
    J Infect Dis 207:240-7. 2013
  2. ncbi request reprint Gastrointestinal infections in the immunocompromised host
    L R Baden
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Infect Dis Clin North Am 15:639-70, xi. 2001
  3. ncbi request reprint Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance"
    L R Baden
    Division of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA
    Clin Infect Dis 33:1654-60. 2001
  4. ncbi request reprint Quinolones and false-positive urine screening for opiates by immunoassay technology
    L R Baden
    Division of Infectious Diseases, Brigham and Women s Hospital, 15 Francis St, PBB A400, Boston, MA 02115, USA
    JAMA 286:3115-9. 2001
  5. pmc Molecular characterization of vancomycin-resistant Enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin
    L R Baden
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
    J Clin Microbiol 40:1160-3. 2002
  6. ncbi request reprint Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole
    L R Baden
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02215, USA
    Transplantation 75:339-43. 2003
  7. ncbi request reprint Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy
    L R Baden
    Division of Infectious Diseases, Brigham and Women s Hospital Dana Farber Cancer Institute, Boston, MA 02215, USA
    Transplantation 76:1632-7. 2003
  8. doi request reprint Infections following facial composite tissue allotransplantation--single center experience and review of the literature
    B M Knoll
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Transplant 13:770-9. 2013
  9. ncbi request reprint Torsades de pointes associated with voriconazole use
    J A Philips
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    Transpl Infect Dis 9:33-6. 2007
  10. doi request reprint Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis
    S P Hammond
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Transpl Infect Dis 15:163-70. 2013

Collaborators

Detail Information

Publications17

  1. pmc First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)
    Lindsey R Baden
    Brigham and Women s Hospital, Rockville, Maryland, USA
    J Infect Dis 207:240-7. 2013
    ..We report the first-in-human safety and immunogenicity assessment of a prototype Ad26 vector-based human immunodeficiency virus (HIV) vaccine in humans...
  2. ncbi request reprint Gastrointestinal infections in the immunocompromised host
    L R Baden
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Infect Dis Clin North Am 15:639-70, xi. 2001
    ..Gastrointestinal defenses and the various mechanisms by which they are impaired are reviewed. The major pathogens and malignancies of this patient population and an approach to their diagnosis, treatment, and prevention are discussed...
  3. ncbi request reprint Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance"
    L R Baden
    Division of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA
    Clin Infect Dis 33:1654-60. 2001
    ..Cultures for detection of VRE in stool samples obtained from patients declared "cleared" are insensitive...
  4. ncbi request reprint Quinolones and false-positive urine screening for opiates by immunoassay technology
    L R Baden
    Division of Infectious Diseases, Brigham and Women s Hospital, 15 Francis St, PBB A400, Boston, MA 02115, USA
    JAMA 286:3115-9. 2001
    ..Millions of assays are performed each year to monitor for substance abuse in various settings. When common medications cross-react with frequently used testing assays, false-positive results can lead to invalid conclusions...
  5. pmc Molecular characterization of vancomycin-resistant Enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin
    L R Baden
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
    J Clin Microbiol 40:1160-3. 2002
    ..8; P = 0.004), and the avoidance of such antibiotics was significantly associated with culture negativity through day 21 (RR = 0.16; P = 0.02)...
  6. ncbi request reprint Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole
    L R Baden
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02215, USA
    Transplantation 75:339-43. 2003
    ..To assess the value of TMP/SMX, we reviewed the experience in our heart transplant patients, all of whom received TMP/SMX (160/800 mg) three times weekly for approximately 8 months after transplantation...
  7. ncbi request reprint Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy
    L R Baden
    Division of Infectious Diseases, Brigham and Women s Hospital Dana Farber Cancer Institute, Boston, MA 02215, USA
    Transplantation 76:1632-7. 2003
    ..Invasive fungal infections (IFI), particularly those caused by Aspergillus and other angioinvasive molds, are associated with an excessive mortality despite therapy...
  8. doi request reprint Infections following facial composite tissue allotransplantation--single center experience and review of the literature
    B M Knoll
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Transplant 13:770-9. 2013
    ..In conclusion, infections following FCTA were related to anatomical, technical and donor/recipient factors. CMV disease occurred in D+/R- recipients after prophylaxis, but was not associated with rejection...
  9. ncbi request reprint Torsades de pointes associated with voriconazole use
    J A Philips
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    Transpl Infect Dis 9:33-6. 2007
    ..The potential for synergistic cardiotoxicity must be carefully considered...
  10. doi request reprint Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis
    S P Hammond
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Transpl Infect Dis 15:163-70. 2013
    ....
  11. pmc Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia
    S Koo
    Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Clin Microbiol Infect 18:E122-7. 2012
    ..Whereas BG eventually declines in patients with IA, IC and PCP, it lacks prognostic value within a clinically meaningful time frame...
  12. ncbi request reprint Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study
    C M Lowry
    Department of Pharmacy, Brigham and Women s Hospital, Boston, MA 02115, USA
    Transpl Infect Dis 9:121-5. 2007
    ..Nebulized amphotericin B deoxycholate (AmBd) has been used to prevent invasive pulmonary aspergillosis after lung transplantation...
  13. doi request reprint Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients
    B B Guzmán-Suarez
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Transpl Infect Dis 14:427-33. 2012
    ....
  14. ncbi request reprint Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6
    W W Seeley
    Department of Neurology, Brigham and Women s Hospital, Boston, MA, USA
    Neurology 69:156-65. 2007
    ..Clinical and laboratory features of the syndrome, however, have not been well characterized...
  15. doi request reprint Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study
    B M Knoll
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Transpl Infect Dis 14:452-60. 2012
    ..The incidence of infection with non-tuberculous mycobacteria (NTM) after lung transplant is insufficiently defined. Data on the impact of NTM infection on lung transplant survival are conflicting...
  16. ncbi request reprint Prevention and therapy of fungal infections in bone marrow transplantation
    L R Baden
    Brigham and Women s Hospital, PBB A4, Dana Farber Cancer Institute, 15 Francis Street, Boston, MA 02215, USA
    Leukemia 17:1038-41. 2003
  17. ncbi request reprint Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis
    C S Graham
    Beth Israel Deaconess Medical Center, Harvard Institute of Medicine, One Deaconess Road, Boston, MA 02215, USA
    Clin Infect Dis 33:562-9. 2001
    ..40-3.07). There is a significantly elevated RR of severe liver disease in persons who are coinfected with HIV and HCV. This has important implications for timely diagnosis and consideration of treatment in coinfected persons...